Immune Support

LL-37 vs BPC-157: Antimicrobial Peptide vs Healing Peptide

Verdict Summary

LL-37 and BPC-157 have overlapping applications in wound healing and infection control but through different mechanisms. BPC-157 has more extensive research; LL-37 adds direct antimicrobial activity.

Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →

At a Glance

DimensionLL-37BPC-157
Primary MechanismAntimicrobial, innate immune modulationAngiogenesis, growth factor upregulation
Wound HealingYes (antimicrobial + healing)Yes (primary indication)
Research DepthModerateExtensive

LL-37 Deep Dive

LL-37 kills bacteria, viruses, and fungi directly while promoting wound healing and modulating innate immune responses. It is particularly relevant for infected wounds or biofilm-related conditions.

BPC-157 Deep Dive

BPC-157 promotes wound healing through angiogenesis, growth factor upregulation, and anti-inflammatory mechanisms. It has the most extensive preclinical evidence of any healing peptide.

How to Choose

Choose LL-37 if…

  • Antimicrobial effects are needed (infected wounds, biofilm)
  • Innate immune modulation is the goal
  • You want direct pathogen-killing activity

Choose BPC-157 if…

  • Tissue healing without infection is the primary goal
  • You want the most researched healing peptide
  • Gut healing or systemic repair is needed

Consider Both If…

LL-37 + BPC-157 may be used together for infected wounds or conditions where both antimicrobial and healing support are needed.

Still Unsure?

Get a personalized recommendation

Take the 5-minute PeptidePilot quiz. Our algorithm evaluates your goals, body, and lifestyle to recommend the right peptide for you — vendor-neutral.

Frequently Asked Questions

More Comparisons